These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 27983526

  • 1. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
    Hashemi M, Danesh H, Bizhani F, Narouie B, Sotoudeh M, Nouralizadeh A, Sharifiaghdas F, Bahari G, Taheri M.
    Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
    Sanaei S, Hashemi M, Rezaei M, Hashemi SM, Bahari G, Ghavami S.
    Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
    [Abstract] [Full Text] [Related]

  • 5. Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia.
    Hashemi M, Bahari G, Naderi M, Sadeghi-Bojd S, Taheri M.
    Cancer Genet; 2016 Nov; 209(11):493-496. PubMed ID: 27886674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.
    Li X, Wang L, Yu J, Xu J, Du J.
    Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
    Li L, Wu J, Sima X, Bai P, Deng W, Deng X, Zhang L, Gao L.
    Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
    [Abstract] [Full Text] [Related]

  • 13. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
    Chen P, Sun R, Pu Y, Bai P, Yuan F, Liang Y, Zhou B, Wang Y, Sun Y, Zhu J, Zhang L, Gao L.
    Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Association of pri-miR34 b/c Gene Polymorphism and Clinicopathologic Data in Breast Cancer Patients.
    Kongton T, Sanguansin S, Saelee P, Thongmee A, Pongstaporn W.
    Asian Pac J Cancer Prev; 2024 Jul 01; 25(7):2415-2420. PubMed ID: 39068575
    [Abstract] [Full Text] [Related]

  • 16. Association between Pri-miR-34b/c rs4938723 polymorphism and bladder cancer risk.
    Hashemi M, Hasanpour V, Danesh H, Bizhani F, Narouie B.
    J Biomed Res; 2018 Sep 06; 33(1):24-9. PubMed ID: 30190447
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysis.
    Ji TX, Zhi C, Guo XG, Zhou Q, Wang GQ, Chen B, Ma FF.
    Asian Pac J Cancer Prev; 2015 Sep 06; 16(14):6099-104. PubMed ID: 26320502
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.